RNA biology is central to understanding how cells function and how diseases develop. Insights from this field are driving the creation of next-generation treatments, including RNA-based therapeutics and vaccines. Our work in this area focuses on supporting research that advances RNA-based platforms, strengthens vaccine development, and improves preparedness for emerging infectious threats.
We invest in building robust, homegrown RNA and vaccine technology capabilities, supporting projects that enable rapid development, testing, and adaptation of vaccines for a range of diseases. Over the coming years, we aim to expand these efforts to accelerate India’s capacity to create innovative RNA-based solutions for public health.
Towards an mRNA vaccine platform
IISc, Bengaluru
Expanding Therapeutic Horizons: A Self-Amplifying mRNA-LNP Platform for Protein Therapeutics
CSIR-Indian Institute of Chemical Technology (IICT), Secunderabad
Development and preclinical evaluation of heterologous prime boost vaccination strategies against tuberculosis
University of Delhi South Campus, New Delhi